{"id":1326,"date":"2024-08-06T14:57:00","date_gmt":"2024-08-06T17:57:00","guid":{"rendered":"https:\/\/www.ufpb.br\/inova\/?post_type=patente&#038;p=1326"},"modified":"2026-02-24T15:10:38","modified_gmt":"2026-02-24T18:10:38","slug":"desenvolvimento-de-polipeptideo-imunogenico-do-sars-cov-2-e-sua-aplicabilidade","status":"publish","type":"patente","link":"https:\/\/www.ufpb.br\/inova\/patente\/desenvolvimento-de-polipeptideo-imunogenico-do-sars-cov-2-e-sua-aplicabilidade\/","title":{"rendered":"Desenvolvimento de polipept\u00eddeo imunog\u00eanico do SARs-CoV-2 e sua aplicabilidade"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Desenvolvimento de polipept\u00eddeo imunog\u00eanico do SARS-CoV-2 e sua aplicabilidade. A inven\u00e7\u00e3o se refere ao processamento caracterizado por pept\u00eddeos imunog\u00eanicos do coronav\u00edrus e sua aplica\u00e7\u00e3o. A inven\u00e7\u00e3o refere-se a um polipept\u00eddeo resultante do v\u00edrus SARS-CoV-2 (SEQ ID NO: 1) almejando a aplica\u00e7\u00e3o deste na proje\u00e7\u00e3o de uma potencial vacina contra a enfermidade COVID-19 ademais de outras doen\u00e7as infecciosas associadas, al\u00e9m da prepara\u00e7\u00e3o de insumo para diagn\u00f3stico por detec\u00e7\u00e3o de SARS-CoV- 2, ou prepara\u00e7\u00e3o de terapias monoclonais como ant\u00edgeno de liga\u00e7\u00e3o a anticorpo neutralizante tanto na medicina humana quanto veterin\u00e1ria.<\/p>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\" open><summary>Modalidade:<\/summary>\n<p class=\"wp-block-paragraph\">Patente de inven\u00e7\u00e3o<\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\" open><summary>Dep\u00f3sito:<\/summary>\n<p class=\"wp-block-paragraph\">06\/08\/2024<\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\" open><summary>Carta-patente:<\/summary>\n<p class=\"wp-block-paragraph\"><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\" open><summary>Transfer\u00eancia tecnol\u00f3gica:<\/summary>\n<p class=\"wp-block-paragraph\">inova@reitoria.ufpb.br<\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\" open><summary>Not\u00edcia relacionada:<\/summary>\n<p class=\"wp-block-paragraph\"><\/p>\n<\/details>\n","protected":false},"excerpt":{"rendered":"<p>Desenvolvimento de polipept\u00eddeo imunog\u00eanico do SARS-CoV-2 e sua aplicabilidade. A inven\u00e7\u00e3o se refere ao processamento [&hellip;]<\/p>\n","protected":false},"featured_media":50,"template":"","meta":{"footnotes":""},"patente_type":[22,23],"class_list":["post-1326","patente","type-patente","status-publish","has-post-thumbnail","hentry","patente_type-quimica-materiais","patente_type-saude-bem-estar"],"_links":{"self":[{"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/patente\/1326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/patente"}],"about":[{"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/types\/patente"}],"version-history":[{"count":1,"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/patente\/1326\/revisions"}],"predecessor-version":[{"id":1327,"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/patente\/1326\/revisions\/1327"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/media\/50"}],"wp:attachment":[{"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/media?parent=1326"}],"wp:term":[{"taxonomy":"patente_type","embeddable":true,"href":"https:\/\/www.ufpb.br\/inova\/wp-json\/wp\/v2\/patente_type?post=1326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}